POAI 0.89 (-21.24%)
US74039M2008• Medical Devices & Instruments• Medical Instruments & Supplies
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. POAI

Predictive Oncology (POAI) Competitor Comparison

We are evaluating the key criteria listed to compare Predictive Oncology (POAI) against its competitors in the Medical Instruments & Supplies industry.

Market Capitalization

43 / 44

Gross Profits

38 / 40

Total Revenue

41 / 43

EBITDA

35 / 44

Free Cashflow

36 / 44

Quick Ratio

14 / 44

Earnings per Share

41 / 44

Dividend yield

0 / 13

Total Cash

35 / 44

Performance 3 years

44 / 44

Performance 5 years

44 / 44

Performance 10 years

44 / 44

Linearity 3 years

39 / 44

Linearity 5 years

43 / 44

Linearity 10 years

34 / 44

Total Rank

22 / 44

Dividend Rank

33 / 44

Valuation Rank

38 / 44

Piotroski Rank

32 / 44

Muliplier Rank

21 / 44

Linearity 5 years - POAI ranking 43 / 44

These are the competitors of Predictive Oncology in the industry Medical Instruments & Supplies ranked by linearity 5 years
1. Becton, Dickinson BDX
47.5
2. Masimo MASI
24.78
3. Cooper Companies COO
19
4. AtriCure ATRC
17.5
5. KORU Medical Systems KRMD
15.97
6. Bausch & Lomb BLCO
14.94
7. Staar Surgical STAA
12.35
8. Pulse Biosciences PLSE
12.07
9. Intuitive Surgical ISRG
11.64
10. BioLife Solutions BLFS
9.45
11. Harvard Bioscience HBIO
9.11
12. Utah Medical Products UTMD
8.58
13. Repligen RGEN
8.37
14. iRhythm Technologies IRTC
7.16
15. Envista Holdings NVST
7.08
16. Pro-Dex PDEX
6.4
17. Haemonetics HAE
6.19
18. Teleflex TFX
5.9
19. NovoCure NVCR
4.99
20. NexGel NXGL
4.7
21. Hologic HOLX
4.58
22. OraSure Technologies OSUR
4.51
23. Merit Medical Systems MMSI
4.38
24. Steris STE
4.35
25. Ansell PD1.F
4.19
26. Atrion ATRI
4.06
27. Nephros NEPH
3.98
28. Baxter BAX
3.83
29. Alcon ALC
3.83
30. Dentsply Sirona XRAY
3.82
31. ICU Medical ICUI
3.8
32. ResMed RMD
3.32
33. AngioDynamics ANGO
3.29
34. NeuroMetrix NURO
2.73
35. Microbot Medical MBOT
2.65
36. Glaukos GKOS
2.49
37. electroCore ECOR
2.34
38. Warby Parker WRBY
2.04
39. Akoya Biosciences AKYA
1.98
40. West Pharmaceutical Services WST
1.94
41. Femasys FEMY
1.48
42. Ekso Bionics Holdings EKSO
1.44
43. Predictive Oncology POAI
1.31
44. LeMaitre Vascular LMAT
0.78
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.